Literature DB >> 12048031

Subtle mutations in the cysteine region of HIV-1 Vif drastically alter the viral replication phenotype.

Mikako Fujita1, Akiko Sakurai, Akiko Yoshida, Sora Matsumoto, Maki Miyaura, Akio Adachi.   

Abstract

Mutations were introduced into the region encoding the two cysteine and nearby amino acid residues of human immunodeficiency virus type 1 (HIV-1) Vif protein and, 12 single-amino-acid viral mutants were constructed. Determination of their growth characteristics in two lymphocytic cell lines revealed that only a single amino acid change in the cysteine region greatly altered the replication phenotype. In particular, the four mutants of amino acid 132 of Vif were grouped into three categories on the basis of their growth potentials. These results indicate that the cysteine region of Vif is critical for the cell-dependent replication efficiency of HIV-1.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12048031     DOI: 10.1016/s1286-4579(02)01580-0

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  4 in total

1.  The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity.

Authors:  Sandra Kao; Mohammad A Khan; Eri Miyagi; Ron Plishka; Alicia Buckler-White; Klaus Strebel
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

2.  Amino acid residues 88 and 89 in the central hydrophilic region of human immunodeficiency virus type 1 Vif are critical for viral infectivity by enhancing the steady-state expression of Vif.

Authors:  Mikako Fujita; Akiko Sakurai; Akiko Yoshida; Maki Miyaura; A Hajime Koyama; Koji Sakai; Akio Adachi
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

3.  Functional analysis of Vif protein shows less restriction of human immunodeficiency virus type 2 by APOBEC3G.

Authors:  Ana Clara Ribeiro; Alexandra Maia e Silva; Mariana Santa-Marta; Ana Pombo; José Moniz-Pereira; Joao Goncalves; Isabel Barahona
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 4.  Viral factors in non-progression.

Authors:  Bin Wang
Journal:  Front Immunol       Date:  2013-12-24       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.